Danish pharmaceutical giant Novo Nordisk has disclosed a data breach affecting patient information from clinical trials. The company is the world's largest insulin producer.
Novo Nordisk confirmed the breach impacted personal data linked to some of its clinical trial programs. The company said it discovered unauthorized access to patient information and is investigating the scope and nature of the incident.
The breach raises questions about data security practices in pharmaceutical research. Clinical trial data typically includes sensitive medical records, personal identifiers, and health histories.
Novo Nordisk stated it is working with cybersecurity experts and notifying relevant regulatory authorities. The company has not disclosed the number of affected patients or specific details about what information was accessed.
This incident follows broader concerns about data protection in the healthcare sector. Regulatory bodies including the FDA and European Medicines Agency oversee clinical trial data security standards.
Novo Nordisk produces insulin and other diabetes treatments serving millions of patients globally. The company has not yet announced remediation measures or timelines for affected trial participants.
GrapheneOS, a privacy-focused Android fork, is on track to ship preinstalled on commercial devices within three years. The project has gained significant momentum in developer circles.
A Chinese-speaking threat actor has exploited vulnerabilities in ZyXEL GS1900 Smart Managed Switches and WordPress to compromise 996 devices and steal over 18,500 database records from government systems.
The ShinyHunters extortion gang claims it breached FBI systems using a previously unknown Oracle PeopleSoft vulnerability, stealing sensitive data on employees and job applicants. The group also defaced the FBI's jobs website.
ShinyHunters claims to have breached the FBI and stolen personal information belonging to agents and job applicants. The alleged theft could expose agents and their families to extortion and counterintelligence threats.